
C4 Therapeutics CCCC
€ 2.29
4.1%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
C4 Therapeutics P/CF 2011-2026 | CCCC
P/CF Jährlich C4 Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.37 | -2.8 | -4.1 | -2.83 | -17 | -21.7 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.37 | -21.7 | -8.47 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 9.33 | 1.41 % | $ 603 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-3.64 | $ 0.87 | -2.13 % | $ 6.4 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 22.38 | 0.81 % | $ 3.71 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Galapagos NV
GLPG
|
-8.78 | $ 28.15 | 1.04 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
14.1 | $ 8.22 | 3.92 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
4.62 | $ 30.95 | -0.34 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
23.4 | $ 8.43 | -0.12 % | $ 76.1 M | ||
|
InflaRx N.V.
IFRX
|
-3.72 | $ 1.97 | -0.51 % | $ 152 M | ||
|
Incyte Corporation
INCY
|
13.8 | $ 98.55 | -0.55 % | $ 19.2 B | ||
|
InMed Pharmaceuticals
INM
|
-0.235 | $ 0.71 | 1.27 % | $ 1.74 M | ||
|
Innoviva
INVA
|
8.24 | $ 22.97 | -0.35 % | $ 1.55 B | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 104.02 | 2.41 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Jaguar Health
JAGX
|
-0.0404 | $ 7.34 | -6.79 % | $ 17.1 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
KalVista Pharmaceuticals
KALV
|
-10.2 | $ 26.68 | 0.02 % | $ 1.44 B | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.2 | $ 1.45 | -2.68 % | $ 235 M | ||
|
Kamada Ltd.
KMDA
|
-30.7 | $ 8.16 | 0.68 % | $ 260 M | ||
|
Krystal Biotech
KRYS
|
42.1 | $ 260.24 | 0.11 % | $ 7.53 B | ||
|
Kazia Therapeutics Limited
KZIA
|
-5.82 | $ 13.58 | 9.34 % | $ 1.8 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
22.9 | $ 220.06 | -2.13 % | $ 4.02 B | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 2.94 | -1.67 % | $ 4.84 M | ||
|
Liquidia Corporation
LQDA
|
-82.6 | $ 38.41 | 0.67 % | $ 3.31 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.08 | 0.62 % | $ 436 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.142 | - | 17.91 % | $ 11.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 23.15 | 3.49 % | $ 2.95 B |